Document bJd2DK3LnxDwXxY501DXZyL1

POSF 3M FLUOROCHEMICAL SUBMISSIONS February, 2002 - May 11, 2004 TOXICOLOGY, EPIDEMIOLOGY AND MEDICAL SURVEILLANCE Click on Study Title to View Report Perfluorooctanesulfonyl fluoride Acute Toxicity 1. Acute Inhalation Limit Toxicity Study of Perfluorooctanesulfonyl Fluoride (POSF) T-7098.3, 3M Reference No. T-7098.3, October 18, 2001. [Submitted July 9, 2003] Repeat Dose 1. Final Report, Oral Toxicity Rangefinder for Perfluorooctane Sulfonyl Fluoride (POSF) in Rats, 3M Study No. T-7098.2, May 11, 2001. [SubmittedMay 11, 2004] Genotoxicity 1. Perfluorooctanesulfonyl Fluoride (POSF) In Vitro Mammalian Chromosome Aberration Test in Human Lymphocyte (Huntingdon Study No. MIN 315/022356), 3M Reference No. T-7661.3, October 22, 2002. [Submitted July 9, 2003] 2. Perfluorooctanesulfonyl Fluoride (POSF) Bacterial Reverse Mutation Test (Huntingdon Study No. MIN 314/022208), 3M Reference No. T-7661.2, October 23, 2002. [Submitted July 9, 2003] Pharmacokinetic Study 1. Final Report, Acute Inhalation Toxicokinetic Study of Perfluorooctanesulfonyl Fluoride (POSF), 3M Study No. T7098.4, November 9, 2001. [SubmittedMay 11, 2004]